Nerve block showdown: which eases Post-Surgery pain best?
NCT ID NCT07001657
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested two different nerve blocks—PECS II and SPSIP—to see which provides better pain relief after breast cancer surgery. 118 women received one of the blocks before surgery, and researchers measured how much opioid painkiller they needed in the first 24 hours. The goal is to find a more effective way to manage pain and reduce opioid use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bupivacaine hydrochloride
- What this could lead to
- If one block works better, it could mean less pain and fewer opioids after breast cancer surgery.
- What could go wrong
- This is a small, completed trial comparing two established techniques, so no major breakthrough is expected. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Antalya Training and Research Hospital
Antalya, 07010, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could opioid tolerance dull the power of local anesthetics?
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple